2024-09-01 2025-08-31 2025-08-31 false 06656603 Bruton Pharmacy Limited 2026-04-01 false iso4217:GBP xbrli:pure 06656603 2024-08-31 06656603 2025-08-31 06656603 2024-09-01 2025-08-31 06656603 2023-08-31 06656603 2024-08-31 06656603 2023-09-01 2024-08-31 06656603 bus:SmallEntities 2024-09-01 2025-08-31 06656603 bus:AuditExempt-NoAccountantsReport 2024-09-01 2025-08-31 06656603 bus:FullAccounts 2024-09-01 2025-08-31 06656603 bus:PrivateLimitedCompanyLtd 2024-09-01 2025-08-31 06656603 core:WithinOneYear 2025-08-31 06656603 core:AfterOneYear 2025-08-31 06656603 core:WithinOneYear 2024-08-31 06656603 core:AfterOneYear 2024-08-31 06656603 core:ShareCapital 2025-08-31 06656603 core:SharePremium 2025-08-31 06656603 core:RevaluationReserve 2025-08-31 06656603 core:OtherReservesSubtotal 2025-08-31 06656603 core:RetainedEarningsAccumulatedLosses 2025-08-31 06656603 core:ShareCapital 2024-08-31 06656603 core:SharePremium 2024-08-31 06656603 core:RevaluationReserve 2024-08-31 06656603 core:OtherReservesSubtotal 2024-08-31 06656603 core:RetainedEarningsAccumulatedLosses 2024-08-31 06656603 core:LandBuildings 2025-08-31 06656603 core:PlantMachinery 2025-08-31 06656603 core:Vehicles 2025-08-31 06656603 core:FurnitureFittings 2025-08-31 06656603 core:OfficeEquipment 2025-08-31 06656603 core:NetGoodwill 2025-08-31 06656603 core:IntangibleAssetsOtherThanGoodwill 2025-08-31 06656603 core:ListedExchangeTraded 2025-08-31 06656603 core:UnlistedNon-exchangeTraded 2025-08-31 06656603 core:LandBuildings 2024-08-31 06656603 core:PlantMachinery 2024-08-31 06656603 core:Vehicles 2024-08-31 06656603 core:FurnitureFittings 2024-08-31 06656603 core:OfficeEquipment 2024-08-31 06656603 core:NetGoodwill 2024-08-31 06656603 core:IntangibleAssetsOtherThanGoodwill 2024-08-31 06656603 core:ListedExchangeTraded 2024-08-31 06656603 core:UnlistedNon-exchangeTraded 2024-08-31 06656603 core:LandBuildings 2024-09-01 2025-08-31 06656603 core:PlantMachinery 2024-09-01 2025-08-31 06656603 core:Vehicles 2024-09-01 2025-08-31 06656603 core:FurnitureFittings 2024-09-01 2025-08-31 06656603 core:OfficeEquipment 2024-09-01 2025-08-31 06656603 core:NetGoodwill 2024-09-01 2025-08-31 06656603 core:IntangibleAssetsOtherThanGoodwill 2024-09-01 2025-08-31 06656603 core:ListedExchangeTraded 2024-09-01 2025-08-31 06656603 core:UnlistedNon-exchangeTraded 2024-09-01 2025-08-31 06656603 core:MoreThanFiveYears 2024-09-01 2025-08-31 06656603 core:Non-currentFinancialInstruments 2025-08-31 06656603 core:Non-currentFinancialInstruments 2024-08-31 06656603 dpl:CostSales 2024-09-01 2025-08-31 06656603 dpl:DistributionCosts 2024-09-01 2025-08-31 06656603 core:LandBuildings 2024-09-01 2025-08-31 06656603 core:PlantMachinery 2024-09-01 2025-08-31 06656603 core:Vehicles 2024-09-01 2025-08-31 06656603 core:FurnitureFittings 2024-09-01 2025-08-31 06656603 core:OfficeEquipment 2024-09-01 2025-08-31 06656603 dpl:AdministrativeExpenses 2024-09-01 2025-08-31 06656603 core:NetGoodwill 2024-09-01 2025-08-31 06656603 core:IntangibleAssetsOtherThanGoodwill 2024-09-01 2025-08-31 06656603 dpl:GroupUndertakings 2024-09-01 2025-08-31 06656603 dpl:ParticipatingInterests 2024-09-01 2025-08-31 06656603 dpl:GroupUndertakings core:ListedExchangeTraded 2024-09-01 2025-08-31 06656603 core:ListedExchangeTraded 2024-09-01 2025-08-31 06656603 dpl:GroupUndertakings core:UnlistedNon-exchangeTraded 2024-09-01 2025-08-31 06656603 core:UnlistedNon-exchangeTraded 2024-09-01 2025-08-31 06656603 dpl:CostSales 2023-09-01 2024-08-31 06656603 dpl:DistributionCosts 2023-09-01 2024-08-31 06656603 core:LandBuildings 2023-09-01 2024-08-31 06656603 core:PlantMachinery 2023-09-01 2024-08-31 06656603 core:Vehicles 2023-09-01 2024-08-31 06656603 core:FurnitureFittings 2023-09-01 2024-08-31 06656603 core:OfficeEquipment 2023-09-01 2024-08-31 06656603 dpl:AdministrativeExpenses 2023-09-01 2024-08-31 06656603 core:NetGoodwill 2023-09-01 2024-08-31 06656603 core:IntangibleAssetsOtherThanGoodwill 2023-09-01 2024-08-31 06656603 dpl:GroupUndertakings 2023-09-01 2024-08-31 06656603 dpl:ParticipatingInterests 2023-09-01 2024-08-31 06656603 dpl:GroupUndertakings core:ListedExchangeTraded 2023-09-01 2024-08-31 06656603 core:ListedExchangeTraded 2023-09-01 2024-08-31 06656603 dpl:GroupUndertakings core:UnlistedNon-exchangeTraded 2023-09-01 2024-08-31 06656603 core:UnlistedNon-exchangeTraded 2023-09-01 2024-08-31 06656603 core:NetGoodwill 2025-08-31 06656603 core:IntangibleAssetsOtherThanGoodwill 2025-08-31 06656603 core:LandBuildings 2025-08-31 06656603 core:PlantMachinery 2025-08-31 06656603 core:Vehicles 2025-08-31 06656603 core:FurnitureFittings 2025-08-31 06656603 core:OfficeEquipment 2025-08-31 06656603 core:AfterOneYear 2025-08-31 06656603 core:WithinOneYear 2025-08-31 06656603 core:ListedExchangeTraded 2025-08-31 06656603 core:UnlistedNon-exchangeTraded 2025-08-31 06656603 core:ShareCapital 2025-08-31 06656603 core:SharePremium 2025-08-31 06656603 core:RevaluationReserve 2025-08-31 06656603 core:OtherReservesSubtotal 2025-08-31 06656603 core:RetainedEarningsAccumulatedLosses 2025-08-31 06656603 core:NetGoodwill 2024-08-31 06656603 core:IntangibleAssetsOtherThanGoodwill 2024-08-31 06656603 core:LandBuildings 2024-08-31 06656603 core:PlantMachinery 2024-08-31 06656603 core:Vehicles 2024-08-31 06656603 core:FurnitureFittings 2024-08-31 06656603 core:OfficeEquipment 2024-08-31 06656603 core:AfterOneYear 2024-08-31 06656603 core:WithinOneYear 2024-08-31 06656603 core:ListedExchangeTraded 2024-08-31 06656603 core:UnlistedNon-exchangeTraded 2024-08-31 06656603 core:ShareCapital 2024-08-31 06656603 core:SharePremium 2024-08-31 06656603 core:RevaluationReserve 2024-08-31 06656603 core:OtherReservesSubtotal 2024-08-31 06656603 core:RetainedEarningsAccumulatedLosses 2024-08-31 06656603 core:NetGoodwill 2023-08-31 06656603 core:IntangibleAssetsOtherThanGoodwill 2023-08-31 06656603 core:LandBuildings 2023-08-31 06656603 core:PlantMachinery 2023-08-31 06656603 core:Vehicles 2023-08-31 06656603 core:FurnitureFittings 2023-08-31 06656603 core:OfficeEquipment 2023-08-31 06656603 core:AfterOneYear 2023-08-31 06656603 core:WithinOneYear 2023-08-31 06656603 core:ListedExchangeTraded 2023-08-31 06656603 core:UnlistedNon-exchangeTraded 2023-08-31 06656603 core:ShareCapital 2023-08-31 06656603 core:SharePremium 2023-08-31 06656603 core:RevaluationReserve 2023-08-31 06656603 core:OtherReservesSubtotal 2023-08-31 06656603 core:RetainedEarningsAccumulatedLosses 2023-08-31 06656603 core:AfterOneYear 2024-09-01 2025-08-31 06656603 core:WithinOneYear 2024-09-01 2025-08-31 06656603 core:Non-currentFinancialInstruments core:CostValuation 2024-09-01 2025-08-31 06656603 core:Non-currentFinancialInstruments core:AdditionsToInvestments 2024-09-01 2025-08-31 06656603 core:Non-currentFinancialInstruments core:RevaluationsIncreaseDecreaseInInvestments 2024-09-01 2025-08-31 06656603 core:Non-currentFinancialInstruments core:DisposalsDecreaseInInvestments 2024-09-01 2025-08-31 06656603 core:Non-currentFinancialInstruments core:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments 2024-09-01 2025-08-31 06656603 core:Non-currentFinancialInstruments core:ImpairmentLossReversalProvisionsForImpairmentInvestments 2024-09-01 2025-08-31 06656603 core:Non-currentFinancialInstruments core:AcquisitionsIncreaseInProvisionsForImpairmentInvestments 2024-09-01 2025-08-31 06656603 core:Non-currentFinancialInstruments core:DisposalsDecreaseInProvisionsForImpairmentInvestments 2024-09-01 2025-08-31 06656603 core:Non-currentFinancialInstruments core:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments 2024-09-01 2025-08-31 06656603 core:Non-currentFinancialInstruments core:CostValuation 2025-08-31 06656603 core:Non-currentFinancialInstruments core:AdditionsToInvestments 2025-08-31 06656603 core:Non-currentFinancialInstruments core:RevaluationsIncreaseDecreaseInInvestments 2025-08-31 06656603 core:Non-currentFinancialInstruments core:DisposalsDecreaseInInvestments 2025-08-31 06656603 core:Non-currentFinancialInstruments core:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments 2025-08-31 06656603 core:Non-currentFinancialInstruments core:ImpairmentLossReversalProvisionsForImpairmentInvestments 2025-08-31 06656603 core:Non-currentFinancialInstruments core:AcquisitionsIncreaseInProvisionsForImpairmentInvestments 2025-08-31 06656603 core:Non-currentFinancialInstruments core:DisposalsDecreaseInProvisionsForImpairmentInvestments 2025-08-31 06656603 core:Non-currentFinancialInstruments core:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments 2025-08-31 06656603 core:Non-currentFinancialInstruments core:CostValuation 2024-08-31 06656603 core:Non-currentFinancialInstruments core:AdditionsToInvestments 2024-08-31 06656603 core:Non-currentFinancialInstruments core:RevaluationsIncreaseDecreaseInInvestments 2024-08-31 06656603 core:Non-currentFinancialInstruments core:DisposalsDecreaseInInvestments 2024-08-31 06656603 core:Non-currentFinancialInstruments core:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments 2024-08-31 06656603 core:Non-currentFinancialInstruments core:ImpairmentLossReversalProvisionsForImpairmentInvestments 2024-08-31 06656603 core:Non-currentFinancialInstruments core:AcquisitionsIncreaseInProvisionsForImpairmentInvestments 2024-08-31 06656603 core:Non-currentFinancialInstruments core:DisposalsDecreaseInProvisionsForImpairmentInvestments 2024-08-31 06656603 core:Non-currentFinancialInstruments core:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments 2024-08-31 06656603 bus:Director1 2024-09-01 2025-08-31 06656603 bus:Director2 2024-09-01 2025-08-31 06656603 core:FurnitureFittingsToolsEquipment 2024-08-31 06656603 core:FurnitureFittingsToolsEquipment 2025-08-31 06656603 core:FurnitureFittingsToolsEquipment 2024-09-01 2025-08-31

Bruton Pharmacy Limited

Registered Number
06656603
(England and Wales)

Unaudited Financial Statements for the Year ended
31 August 2025

Bruton Pharmacy Limited
Company Information
for the year from 1 September 2024 to 31 August 2025

Directors | Divyeshkumar Ashokbhai Patel
| Swapnkumar Mukeshbhai Patel

Registered Address | 23 Rossall Close
| Hornchurch
| RM11 1BP

Registered Number | 06656603 (England and Wales)

Bruton Pharmacy Limited
Statement of Financial Position
31 August 2025

| Notes | 2025 |  | 2024
--- | --- | --- | --- | ---
|  | £ |  | £ |  | £ |  | £
Fixed assets |  |  |  |  |  |  |  |
Tangible assets | 3 |  |  | 734 |  |  |  | 979
|  |  |  | 734 |  |  |  | 979
Current assets |  |  |  |  |  |  |  |
Stocks | 4 | 65,000 |  |  |  | 85,000 |  |
Debtors |  | 407,362 |  |  |  | 451,069 |  |
Cash at bank and on hand |  | 7,012 |  |  |  | 91,073 |  |
|  | 479,374 |  |  |  | 627,142 |  |
Creditors amounts falling due within one year | 5 | (341,781) |  |  |  | (408,866) |  |
Net current assets (liabilities) |  |  |  | 137,593 |  |  |  | 218,276
Total assets less current liabilities |  |  |  | 138,327 |  |  |  | 219,255
Creditors amounts falling due after one year | 6 |  |  | (135,681) |  |  |  | (145,786)
Provisions for liabilities | 7 |  |  | (184) |  |  |  | (245)
Net assets |  |  |  | 2,462 |  |  |  | 73,224
Capital and reserves |  |  |  |  |  |  |  |
Called up share capital |  |  |  | 4 |  |  |  | 4
Profit and loss account |  |  |  | 2,458 |  |  |  | 73,220
Shareholders' funds |  |  |  | 2,462 |  |  |  | 73,224

- The company was entitled to exemption from audit for this reporting period under section 477 of the Companies Act 2006 relating to small companies.
- The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
- The Directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
- These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.
- The directors have chosen to not file a copy of the company’s profit and loss account under section 444 (5A) Companies Act 2006.

The financial statements were approved and authorised for issue by the Board of Directors on 1 April 2026, and are signed on its behalf by:
Swapnkumar Mukeshbhai Patel Director Registered Company No. 06656603

Bruton Pharmacy Limited
Notes to the Financial Statements
for the year ended 31 August 2025

1. | Accounting policies
--- | ---

| Statutory information
--- | ---
| The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

| Statement of compliance
--- | ---
| The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.

| Basis of preparation
--- | ---
| The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).

| Functional and presentation currency
--- | ---
| The financial statements are presented in sterling and this is the functional currency of the company.

| Turnover policy
--- | ---
| Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services.

| Employee benefits
--- | ---
| Contributions to defined contribution plans are expensed in the period to which they relate.

| Foreign currency translation
--- | ---
| Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.

| Current taxation
--- | ---
| Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.

| Deferred tax
--- | ---
| Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.

| Tangible fixed assets and depreciation
--- | ---
| Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on all tangible fixed assets as follows:

|  | Reducing balance (%) |  | Straight line (years)
| Fixtures and fittings | 25 |  | -
| Office Equipment | - |  | 3

| Stocks and work in progress
--- | ---
| Inventories are valued at the lower of cost and estimated selling price (less any associated costs to enable such sales to complete).

2. | Average number of employees
--- | ---

|  | 2025 |  | 2024
| Average number of employees during the year | 5 |  | 5

3. | Tangible fixed assets
--- | ---

|  | Fixtures & fittings |  | Office Equipment |  | Total
--- | --- | --- | --- | --- | --- | ---
|  | £ |  | £ |  | £
| Cost or valuation
| At 01 September 24 | 2,801 |  | 1,610 |  | 4,411
| At 31 August 25 | 2,801 |  | 1,610 |  | 4,411
| Depreciation and impairment
| At 01 September 24 | 1,822 |  | 1,610 |  | 3,432
| Charge for year | 245 |  | - |  | 245
| At 31 August 25 | 2,067 |  | 1,610 |  | 3,677
| Net book value
| At 31 August 25 | 734 |  | - |  | 734
| At 31 August 24 | 979 |  | - |  | 979

4. | Stocks
--- | ---

|  | 2025 |  | 2024
--- | --- | --- | --- | ---
|  | £ |  | £
| Finished goods | 65,000 |  | 85,000
| Total | 65,000 |  | 85,000

5. | Creditors: amounts due within one year
--- | ---

|  | 2025 |  | 2024
--- | --- | --- | --- | ---
|  | £ |  | £
| Trade creditors / trade payables | 140,396 |  | 186,211
| Bank borrowings and overdrafts | 100,000 |  | 94,571
| Taxation and social security | 3,852 |  | 20,521
| Other creditors | 56,283 |  | 59,842
| Accrued liabilities and deferred income | 41,250 |  | 47,721
| Total | 341,781 |  | 408,866

| Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.

6. | Creditors: amounts due after one year
--- | ---

|  | 2025 |  | 2024
--- | --- | --- | --- | ---
|  | £ |  | £
| Other creditors | 135,681 |  | 145,786
| Total | 135,681 |  | 145,786

| Other creditors' balance of £135,681 (2024: £145,786) includes £7,500 (2024: £17,500) amount payable to Bounce back Loan, and £103,391 (2024: £105,750) amount payable to S&L Murphy Ltd, £24,790 (2024: £22,536) amount payable to Reborn Healthcare for the loan received.

7. | Provisions for liabilities
--- | ---

|  | 2025 |  | 2024
--- | --- | --- | --- | ---
|  | £ |  | £
| Net deferred tax liability (asset) | 184 |  | 245
| Total | 184 |  | 245